ANVISA registration 80812770021Active

GLYCATED HEMOGLOBIN (HbA1C)

Name: GLYCATED HEMOGLOBIN (HbA1C) — ANVISA registration 80812770021
Creator: EUROLYSER DIAGNOSTICA GMBH
Keywords: GLYCATED HEMOGLOBIN (HbA1C), HEMOGLOBINA GLICADA (HbA1C), HbA1c test kit, 80812770021, Risk Class II, ANVISA registration

ANVISA Registration Number: 80812770021MEX GLOBAL EQUIPAMENTOS PARA DIAGNÓSTICOS LTDAEUROLYSER DIAGNOSTICA GMBHRisk Class II

Verified

Device names

Technical name: GLYCATED HEMOGLOBIN (HbA1C)
Commercial name: HbA1c test kit
Risk class: Class II

Registration details

Registration Number: 80812770021
Process Number: 25351400115201515
CNPJ: 11098622000110

Company information

Registration Holder: MEX GLOBAL EQUIPAMENTOS PARA DIAGNÓSTICOS LTDA
Manufacturer: EUROLYSER DIAGNOSTICA GMBH
Manufacturing Country: Austria

Dates and status

Publication Date: Sep 08, 2015
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80812770021 and manufactured by EUROLYSER DIAGNOSTICA GMBH. The registration is held by MEX GLOBAL EQUIPAMENTOS PARA DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.